Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis - Filippi, M; Danesi, R; Derfuss, T; Duddy, M; Gallo, P; Gold, R (J Neurol, 2022)